SUMMARY Previous work has shown that leucocyte adhesiveness/aggregation (LAA), as measured by the leukergy test, correlates well with disease severity in rheumatic patients. As LAA is probably a manifestation of the acute phase reaction various components of the acute phase reaction were measured in order to identify the best marker of disease activity. In addition to LAA, the following variables were measured in 79 patients with various rheumatic diseases and in 10 controls: white blood cell and platelet counts, erythrocyte sedimentation rate, haptoglobin, fibrinogen, C reactive protein, albumin, globulin, caeruloplasmin, a,, a2, P, and y globulin, and haemoglobin concentrations. 
The present investigation is an extension of a previous attempt to develop a laboratory tool for the assessment of disease activity in rheumatic patients. 1 Total white blood cell count and erythrocyte sedimentation rate (ESR) were compared by the leukergy test, which determines the extent of leucocyte adhesiveness and aggregation (LAA). It was found that LAA measurements yielded the most reliable results and pointed to the usefulness of the test in clinical work.
As LAA is only one of many variables in the acute phase reaction which may change during inflammation (for a concise description of the latter see reference 2) it was decided to examine a large number of these variables and correlate them with the state of disease activity in various types of rheumatic disorders. Although LAA again gave the best results, some other markers, such as C reactive moderate impairment of their daily activities and were given full doses of conventional antiinflammatory drugs. Group C-Severe disease; patients in hospital for intensive treatment owing to florid disease, with significant complaints, physical findings, and inability to continue normal daily activities. At times, significant involvement of an internal organ, such as lupus nephritis, was sufficient to classify the patient in this category.
CONTROLS
Ten healthy paramedical personnel volunteered to serve as controls.
METHODS
The LAA was determined by a previously described method.' [3] [4] [5] [6] In brief, a citrated sample of blood (1:4 dilution of a 3*8% sodium citrate solution, i.e., one volume of citrate and three volumes of blood) was drawn into a plastic syringe. Several The erythrocyte sedimentation rate was determined by the method of Westergren. 7 The concentration of haptoglobin in the serum was determined by radial immunodiffusion (according to the method of Mancini et at8) using a commercial antibody to human haptoglobin.
The plasma concentration of fibrinogen was determined according to the method of Clauss.9
The concentration of C reactive protein (CRP) was determined by electroimmunoassayl°using specific antiserum and a standard reference serum. The serum concentration of albumin and globulin was determined in the sequential multiple analyser SMA 12.
The concentration of caeruloplasmin in the serum was determined by an enzymatic assay as described elsewhere. " The various globulins were determined by electrophoresis using a Beckman model R-101 electrophoresis cell.
STATISTICAL ANALYSIS
Statistical analysis was performed using the BMDP (Biomedical computer programs, P series, 1979, University of California). One way analysis of variance was done for each laboratory variable to verify whether at least one significant difference existed between test groups and the control. A multiple regression analysis was performed12 using the group (0=control, 1=mild, 2=moderate, and 3=severe) as the outcome variable to ascertain the variable that best discriminated between groups of disease activity. The percentage of correct classification into the appropriate group of severity was calculated by means of discriminant analysis13 for the variables that showed the best ability to classify the patients.
Results
We examined 79 patients and 10 controls. Table 1 shows the classification of the patients into groups of disease activity and the age and sex of patients and controls. Of the 27 patients in the group with mild disease, 20 had rhematoid arthritis (RA), three had psoriatic arthritis, two had monarthritis of undefined aetiology, one had gouty arthritis, and the remaining one mixed connective tissue disease. In the group with moderate disease there were 28 patients, of whom 21 had RA, two had systemic lupus erythematosus, two had psoriatic arthritis, one had monarthritis of undefined aetiology, and one juvenile arthritis. In the group with severe disease 23 patients had RA and one psoriatic arthritis. Table 2 shows the results of the laboratory variables examined and the level of significance for the analysis of variance. It can be seen that 10 variables attained significance (p<005) in this analysis-namely, LAA, total white blood cell count, platelet count, erythrocyte sedimentation rates at the first (ESR 1) and second (ESR 2) hour, haptoglobin, C reactive protein, albumin, caeruloplasmin, and haemoglobin. Table 3 shows the correlation (Pearson) between the laboratory vari- Table 8 gives the results of classification by LAA+ESR 1, and [17] [18] [19] [20] [21] In summary, the state of leucocyte adhesiveness/ aggregation is a simple, convenient, and reliable test for assessing the severity of disease in patients with various rheumatic diseases. In addition to its potential clinical usefulness, this variable also contributes to our understanding of the role of leucocytes in inflammation.
adhesiveness/aggregation. 
